Navigation Links
Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019
Date:5/15/2012

an, Market Forecast ($m), 2011-2019 42Table 30:Neuroendocrine Carcinoma Therapeutics – Phase III Pipeline, 2012 53Table 31:Neuroendocrine Carcinoma Therapeutics – Phase II Pipeline, 2012 54Table 32:Neuroendocrine Carcinoma Therapeutics – Phase I Clinical Pipeline, 2012 54Table 33:Neuroendocrine Carcinoma Therapeutics – Preclinical Pipeline, 2012 54Table 34: Neuroendocrine Carcinoma Therapeutics –Phase III Promising Drugs in Clinical Development 58Table 35:Adverse events of Bevacizumab and Peginterferon alfa-2b 59Table 36:Neuroendocrine Carcinoma Therapeutics– Clinical Trials by Region/Country, 2012 62Table 37:Neuroendocrine Carcinoma Therapeutics – Clinical Trials by Phase, 2012 63Table 38:Neuroendocrine Carcinoma Therapeutics – Clinical Trials by Trial Status, 2012 64Table 39:Neuroendocrine Carcinoma Therapeutics – Clinical Trials by Overall Sponsors, 2012 65Table 40: Neuroendocrine Carcinoma Therapeutics – Clinical Trials by Prominent Sponsors, 2012 66Table 41: Neuroendocrine Carcinoma Therapeutics – Clinical Trials by Top Companies, 2012 67Table 42: Advanced Accelerator Applications S.A. – Neuroendocrine Carcinoma Pipeline Product, 2012 71Table 43:Novartis AG – Oncology Pipeline Products, 2012 72Table 44:Novartis AG – Neuroendocrine Carcinoma Pipeline Product, 2012 72Table 45:F. Hoffmann-La Roche- Oncology Pipeline Products, 2012 74Table 46:F. Hoffmann-La Roche – Neuroendocrine Carcinoma Pipeline Product, 2012 74Table 47:Ipsen SA- Oncology Pipeline Products, 2012 75Table 48:Ipsen SA- Neuroendocrine Carcinoma Pipeline Product, 2012 75Table 49:Neuroendocrine Carcinoma Therapeutics – Other Future Players, 2012 76Table 50:Neuroendocrine Carcinoma Therapeutics, Global, Deals ($m), 2012 77

List of Figures

Figure 1: Patient Share of Neuroendocrine Carcinoma* in the Seven Major Markets, 2011 9Figure 2:Treatment Algorithm for GEP-NETs 19Figure 3:Referral P
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Positive Phase 2 Trial Results from Neuroendocrine Tumor Cohort Presented at CIRSE
2. Cylene Pharmaceuticals Initiates Phase II Clinical Trial of Quarfloxin (CX-3543) in Patients With Carcinoid/Neuroendocrine Tumors
3. Childhood Obesity Linked to Increased Risk of Hepatocellular Carcinoma in Adulthood
4. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
5. SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma
6. Targeted Gold Nanoparticles and Noninvasive Radio Fields Attacking One of the Deadliest and Least Curable Types of Cancer: Pancreatic Carcinoma
7. Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
8. Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma
9. Aratana Therapeutics Appoints Craig Tooman to Board of Directors
10. Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy
11. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Best Sanitizers, Inc., the first company ... sanitizer, asks food processors and food handling professionals to ... they’re currently using to Best Sanitizers’ Alpet® E3 ... to fighting cross-contamination and the spread of pathogens in ... are key criteria that make a hand sanitizer most ...
(Date:8/28/2014)... Aug. 28, 2014 ... market research report is available ... Whole Exome Sequencing Market by ... Target Enrichment), by Services (Sequencing), ... by Application (Cancer, Monogenic disorders) ...
(Date:8/28/2014)... Sterlitech is proud to announce that it is ... of products . These additional products increase the ... filters with surface charges. , “We have ... membrane process testing equipment, and correspondingly, a wider demand ... Sterlitech President Mark Spatz. “The addition of Synder ...
(Date:8/28/2014)... Vt. (PRWEB) August 28, 2014 ... testing around the world is available from Strategic ... diagnostics companies. “ Industrial Microbiology Market Review, Fourth ... Industrial Market ” (IMMR—4) tracks and compares microbiology ... in North America, Europe and Asia, and forecasts ...
Breaking Biology Technology:Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 3Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 2Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 3Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 4Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 5Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 6Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 7Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 8Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 9Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 10Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 11Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 12Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 13Sterlitech Corporation Enhances Its Selection of Flat Sheet Membrane Filters 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3
... SYDNEY, June 3 /PRNewswire-Asia/ -- ... that it had raised A$47 million through a placement ... strengthens the company,s balance sheet as Pharmaxis moves toward,the ... for cystic,fibrosis. , Pharmaxis will ...
... June 3 Speaker of the House Nancy Pelosi (D-CA) ... the unveiling of a statue of President Ronald Reagan today ... got her facts all wrong, misleading people again, this time ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO ) , ...
... JERUSALEM, June 3 The Gamida Cell-Teva Joint Venture,announced today that ... two in Valencia, have joined the Excel study. , , ... - Hospital Clinic of Barcelona, Barcelona, Principal ... Universitario de Valencia, Valencia, Principal Investigator, Dr. Cristina ...
Cached Biology Technology:Pharmaxis Announces Placement of $47 Million and Share Purchase Plan 2Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 2Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 3
(Date:8/29/2014)... release is available in German . ... players in the natural nitrogen cycle on Earth and ... bacteria were thought to depend on nitrite as their ... by Holger Daims, a microbiologist at the University of ... hydrogen as an alternative source of energy. The oxidation ...
(Date:8/29/2014)... them: modern materials that are light, flexible and highly ... or electronic paper. , Making such concepts affordable enough ... way of working with copper nanowires and a PVA ... success in the field of ultra-lightweight "aerogel monoliths" has ... silver nanowires. , By turning instead to copper, ...
(Date:8/28/2014)... of bacterial culprits that may drive inflammatory bowel diseases ... patients, own intestinal immune responses as a guide. , ... Cell . , Trillions of bacteria exist within ... in the development and progression of IBD. Yet it,s ... affect a person,s susceptibility to IBD and its potential ...
Breaking Biology News(10 mins):Hydrogen powers important nitrogen-transforming bacteria 2Hydrogen powers important nitrogen-transforming bacteria 3Copper shines as flexible conductor 2Yale study identifies possible bacterial drivers of IBD 2
... Damselfish are killing head corals and adding stress ... poor condition from global climate change, coral diseases, hurricanes, ... favorite homestead, will take the pressure off the other ... online journal PLoS ONE . The small, ...
... miles of the nation,s infrastructure of water ... of its useful life, but the mostly ... attention because of this "invisibility," said Sunil ... and environmental engineering (CEE). http://www.cee.vt.edu/index.php?do=view&content=0&apps=2&level=2&id=17&pid=b024555fa7f439a27509de488a7b5749 ...
... most likely to occur on Sunday, in less than 6 ... wearing black and white bathing suits, a first of its ... analyzed statistics from shark attacks that occurred in Florida,s Volusia ... 1956 and 2008. They also spent a year observing people ...
Cached Biology News:Distressed damsels stress coral reefs 2Efforts underway at Virginia Tech to address deterioration of nation's water pipes 2Case study analyzes why, where and when of leading shark attack site 2Case study analyzes why, where and when of leading shark attack site 3
... is a thermostable DNA polymerase derived ... at temperatures above 70°C, it was ... PCR and remains the predominant enzyme ... an intrinsic 5'?3' structure-dependent exonuclease activity, ...
Rabbit anti Xanthine Oxidase Xanthine Oxidase, Bovine Buttermilk...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (E6027) or contact customer s...
... large numbers of samples may be carried out ... operator attention. System control and data processing ... 4900. The elegant, powerful and very easy ... Windows 98 and 2000., The supplied detector is ...
Biology Products: